Elaine Healy Sells 4,000 Shares of Consensus Cloud Solutions (NASDAQ:CCSI) Stock

Consensus Cloud Solutions director Elaine Healy sold 4,000 shares on June 2 at an average $34.27, for about $137,080, according to an SEC filing. After the sale, she directly owned 27,658 shares. The stock last traded around $34.36. The company reported Q1 EPS of $1.52 on revenue of $88.47M and issued Q2 2026 EPS guidance of 1.430–1.530.

Original reporting
Published Jun 4, 2026, 9:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 10:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Elaine Healy Sells 4,000 Shares of Consensus Cloud Solutions (NASDAQ:CCSI) Stock — source image
Decision brief

The 30-second read

$CCSIBearishLow
01

Why it matters

For trading, the actionable element is the insider sale disclosure; however, without accompanying changes to guidance, contracts, or investigations, the incremental signal is weak.

02

Market read

CCSI’s stock context includes a recent earnings beat and raised analyst targets, but the new incremental datapoint is director selling at ~$34.27.

03

What to watch

The article also cites strong liquidity ratios and recent guidance/EPS beat; traders may weight those more than a single director’s sale size.

Relevance 6/10Novelty 3/10Timing: After the June 2 insider sale disclosure, with stock trading around $34 on Thursday.

Background

The piece is primarily an SEC Form 4-style insider transaction recap, with supporting context on recent earnings (May 7) and analyst coverage.

Company-level read

Ticker impact

$CCSIBearishMedium confidence
Context

Director Elaine Healy sold 4,000 shares via SEC-disclosed Form 4, reducing her stake by 12.64% at an average $34.27.

Expected impact

Likely limited near-term impact; any effect should be small versus earnings/guidance backdrop.

Evidence & confidence

The only company-specific new fact is a director’s disclosed sale; such transactions often reflect diversification and are not, by themselves, a fundamental catalyst.

Market effects

Minimal; this is company-specific insider activity with no sector-wide regulatory/product development.

None indicated; US-listed single-name filing.

None indicated.

Counterpoint

Director selling can be routine (taxes/diversification) and may not reflect bearish fundamentals, especially after a recent earnings beat.

Key entities

  • Elaine Healy

    Consensus Cloud Solutions director who sold 4,000 shares on June 2, disclosed via SEC filing.

  • Consensus Cloud Solutions, Inc.

    NASDAQ-listed cloud consulting/managed services provider; subject of the insider sale and recent earnings/guidance context.

Related articles

$CCSIMed

Consensus Cloud’s (CCSI) Buyback Doubles, But Growth Has A Catch

Consensus Cloud Solutions (CCSI) reported Q2 revenue of $91.4M, up 4.1%, and net income of $27.4M, up 31.7%. The board doubled its buyback authorization to $200M. Corporate segment revenue rose 9.3%, while the SoHo business declined 4.7%. Adjusted EBITDA was flat at $48.3M. The company reaffirmed its 2026 guidance and issued steady Q3 guidance.

$CCSIMedAI 8/10

Consensus Cloud Solutions (CCSI) Q2 2026 Earnings Call Transcript

Consensus Cloud Solutions (CCSI) reported Q2 2026 revenue of $91.4M (+4.1% YoY). Corporate revenue rose to $60.5M (+9.3%) and SoHo revenue fell to $30.9M (-4.7%). Adjusted EBITDA was $48.3M (52.9% margin) and adjusted EPS was $1.49. Full-year 2026 guidance: $350M-$364M revenue and $182M-$193M adjusted EBITDA.

$CCSIHigh

Consensus Cloud Solutions, Inc. (CCSI): Results of Operations and Financial Condition

Consensus Cloud Solutions, Inc. (CCSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Consensus Cloud Solutions, Inc. Reports Second Quarter 2026 Results Reaffirms Full Year 2026 and Releases Q3 2026 Guidance Increases Stock Buyback Program to $200 Million LOS ANGELES -- Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) today reported financial results for the second

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.